⌘K (Command K) to search

Sign in Sign up free

8-KAccepted Mar 22, 6:11 AM ET

Neos Therapeutics, Inc. 8-K

Neos Therapeutics, Inc.

sec.gov View full filing

Accepted (ET)

6:11 AM

Mar 22, 2021

Filed

Mar 22, 2021

Documents

6

Size

817.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.

Filing details

Company: Neos Therapeutics, Inc.
CIK: 0001467652
Form: 8-K
Accepted: Mar 22, 6:11 AM ET
Filed: Mar 22, 2021
Size: 817.2 KB
Accession: 0001213900-21-016770

Documents · 6

ea138106-8k_neostherapeutics.htmPrimary
CURRENT REPORT
ea138106ex3-1_neostherap.htm
FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEOS THERAPEUTICS, INC
ea138106ex3-2_neostherap.htm
SECOND AMENDED AND RESTATED BYLAWS OF NEOS THERAPEUTICS, INC
ea138106ex10-1_neostherap.htm
CONSENT, WAIVER AND SIXTH AMENDMENT TO FACILITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, LLC, DEERFIELD PRIVATE DESIGN
ea138106ex10-2_neostherap.htm
CONSENT, WAIVER AND AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, AND ENCINA BUSINESS
ea138106ex99-1_neostherap.htm
PRESS RELEASE DATED MARCH 22, 2021